Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Avadel Pharmaceuticals Total Assets 2010-2025 | AVDL

Avadel Pharmaceuticals total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
Avadel Pharmaceuticals Annual Total Assets
(Millions of US $)
2024 $164
2023 $165
2022 $133
2021 $247
2020 $312
2019 $151
2018 $190
2017 $253
2016 $245
2015 $215
2014 $174
2013 $116
2012 $117
2011 $69
2010 $75
2009 $94
Avadel Pharmaceuticals Quarterly Total Assets
(Millions of US $)
2025-03-31 $168
2024-12-31 $164
2024-09-30 $158
2024-06-30 $158
2024-03-31 $168
2023-12-31 $165
2023-09-30 $203
2023-06-30 $201
2023-03-31 $141
2022-12-31 $133
2022-09-30 $146
2022-06-30 $158
2022-03-31 $221
2021-12-31 $247
2021-09-30 $264
2021-06-30 $283
2021-03-31 $293
2020-12-31 $312
2020-09-30 $328
2020-06-30 $341
2020-03-31 $208
2019-12-31 $151
2019-09-30 $156
2019-06-30 $166
2019-03-31 $174
2018-12-31 $190
2018-09-30 $269
2018-06-30 $295
2018-03-31 $352
2017-12-31 $253
2017-09-30 $277
2017-06-30 $259
2017-03-31 $259
2016-12-31 $245
2016-09-30 $248
2016-06-30 $250
2016-03-31 $255
2015-12-31 $215
2015-09-30 $0
2015-06-30 $187
2015-03-31 $186
2014-12-31 $174
2014-09-30 $164
2014-06-30 $175
2014-03-31 $182
2013-12-31 $116
2013-09-30 $117
2013-06-30 $118
2013-03-31 $123
2012-12-31 $117
2012-09-30 $0
2012-06-30 $134
2012-03-31 $137
2011-12-31 $69
2011-09-30 $73
2011-06-30 $76
2011-03-31 $70
2010-12-31 $75
2010-09-30 $77
2010-06-30 $70
2010-03-31 $81
2009-12-31 $94
2009-09-30 $98
2009-06-30 $93
2009-03-31 $91
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.017B $0.169B
Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $79.248B 30.48
Zoetis (ZTS) United States $64.907B 24.22
Daiichi Sankyo, - (DSNKY) Japan $46.828B 24.00
Takeda Pharmaceutical (TAK) Japan $43.656B 8.91
BeOne Medicines - (ONC) Cayman Islands $33.004B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.084B 0.00
Summit Therapeutics (SMMT) United States $19.584B 0.00
Merck (MKKGY) Germany $16.168B 11.85
Shionogi (SGIOY) Japan $14.172B 14.20
Neurocrine Biosciences (NBIX) United States $12.718B 37.94
United Therapeutics (UTHR) United States $12.391B 10.72
Orion OYJ (ORINY) Finland $11.482B 27.67
IPSEN (IPSEY) France $10.802B 0.00
Stevanato Group S.p.A (STVN) Italy $7.483B 45.76
Grifols, S.A (GRFS) Spain $7.357B 0.00
Corcept Therapeutics (CORT) United States $7.123B 59.44
Ionis Pharmaceuticals (IONS) United States $6.851B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.717B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.853B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.358B 0.00
Hypermarcas (HYPMY) Brazil $2.987B 19.65
Crinetics Pharmaceuticals (CRNX) United States $2.677B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.602B 9.12
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.451B 13.25
NewAmsterdam Pharma (NAMS) Netherlands $2.449B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.294B 0.00
Ocular Therapeutix (OCUL) United States $1.845B 0.00
Endo (NDOI) United States $1.800B 0.00
ARS Pharmaceuticals (SPRY) United States $1.736B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.703B 0.00
Evotec AG (EVO) Germany $1.413B 0.00
Dyne Therapeutics (DYN) United States $1.401B 0.00
Guardian Pharmacy Services (GRDN) United States $1.323B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.249B 18.13
Harrow (HROW) United States $1.165B 0.00
Ardelyx (ARDX) United States $1.014B 0.00
Akebia Therapeutics (AKBA) United States $0.968B 0.00
Collegium Pharmaceutical (COLL) United States $0.959B 5.18
Enliven Therapeutics (ELVN) United States $0.923B 0.00
ProKidney (PROK) United States $0.811B 0.00
Xeris Biopharma Holdings (XERS) United States $0.796B 0.00
Cronos Group (CRON) Canada $0.764B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.716B 0.00
KalVista Pharmaceuticals (KALV) United States $0.681B 0.00
Zevra Therapeutics (ZVRA) United States $0.607B 0.00
Relay Therapeutics (RLAY) United States $0.603B 0.00
Xencor (XNCR) United States $0.592B 0.00
Organogenesis (ORGO) United States $0.586B 0.00
Tourmaline Bio (TRML) United States $0.568B 0.00
Theravance Biopharma (TBPH) United States $0.558B 0.00
USANA Health Sciences (USNA) United States $0.547B 11.01
Elite Pharmaceuticals (ELTP) United States $0.546B 0.00
Bioventus (BVS) United States $0.536B 13.58
Oruka Therapeutics (ORKA) United States $0.509B 0.00
Siga Technologies (SIGA) United States $0.472B 9.87
Savara (SVRA) United States $0.448B 0.00
Aquestive Therapeutics (AQST) United States $0.381B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.376B 10.17
AleAnna (ANNA) United States $0.339B 0.00
Nanobiotix S.A (NBTX) France $0.325B 0.00
Altimmune (ALT) United States $0.299B 0.00
Aldeyra Therapeutics (ALDX) United States $0.299B 0.00
Esperion Therapeutics (ESPR) United States $0.281B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.277B 0.00
Nektar Therapeutics (NKTR) United States $0.269B 0.00
Heron Therapeutics (HRTX) United States $0.264B 0.00
Nature's Sunshine Products (NATR) United States $0.259B 16.10
OmniAb (OABI) United States $0.233B 0.00
Galectin Therapeutics (GALT) United States $0.230B 0.00
Larimar Therapeutics (LRMR) United States $0.222B 0.00
4D Molecular Therapeutics (FDMT) United States $0.208B 0.00
MediWound (MDWD) Israel $0.201B 0.00
China SXT Pharmaceuticals (SXTC) China $0.181B 0.00
Lyell Immunopharma (LYEL) United States $0.175B 0.00
Journey Medical (DERM) United States $0.171B 0.00
Profound Medical (PROF) Canada $0.167B 0.00
Aclaris Therapeutics (ACRS) United States $0.166B 0.00
Liminatus Pharma (LIMN) United States $0.163B 0.00
Lexeo Therapeutics (LXEO) United States $0.157B 0.00
Korro Bio (KRRO) United States $0.140B 0.00
Avita Medical (RCEL) United States $0.140B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.124B 0.00
Cardiol Therapeutics (CRDL) Canada $0.123B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Inhibikase Therapeutics (IKT) United States $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Achieve Life Sciences (ACHV) Canada $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.087B 19.75
Metagenomi (MGX) United States $0.086B 0.00
Surrozen (SRZN) United States $0.086B 0.00
Avalo Therapeutics (AVTX) United States $0.085B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Nutriband (NTRB) United States $0.080B 0.00
Vivani Medical (VANI) United States $0.079B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.069B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.069B 0.00
Dominari Holdings (DOMH) United States $0.067B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Context Therapeutics (CNTX) United States $0.065B 0.00
Rafael Holdings (RFL) United States $0.059B 0.00
DURECT (DRRX) United States $0.058B 0.00
Telomir Pharmaceuticals (TELO) United States $0.056B 0.00
Unicycive Therapeutics (UNCY) United States $0.055B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 38.33
Century Therapeutics (IPSC) United States $0.047B 0.00
NRx Pharmaceuticals (NRXP) United States $0.047B 0.00
Jupiter Neurosciences (JUNS) United States $0.046B 0.00
Klotho Neurosciences (KLTO) United States $0.044B 0.00
Prelude Therapeutics (PRLD) United States $0.044B 0.00
Gain Therapeutics (GANX) United States $0.044B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Mural Oncology (MURA) Ireland $0.039B 0.00
Enlivex Therapeutics (ENLV) Israel $0.035B 0.00
PolyPid (PYPD) Israel $0.034B 0.00
Karyopharm Therapeutics (KPTI) United States $0.033B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
Plus Therapeutics (PSTV) United States $0.029B 0.00
FibroGen (FGEN) United States $0.028B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
Cosmos Health (COSM) United States $0.027B 0.00
Vivos Therapeutics (VVOS) United States $0.026B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Incannex Healthcare (IXHL) Australia $0.017B 0.00
BioLineRx (BLRX) Israel $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
Carisma Therapeutics (CARM) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Lyra Therapeutics (LYRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
VYNE Therapeutics (VYNE) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 11.35
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.28
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00